This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Vistagen Therapeutics, Inc.. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Innovations of Klaus Laue in Chiral Kynurenine Synthesis
Introduction
Klaus Laue is a notable inventor based in Buchs, Switzerland. He has made significant contributions to the field of chemistry, particularly in the synthesis of chiral kynurenine compounds. With a total of two patents to his name, Laue's work is recognized for its potential applications in various industries.
Latest Patents
Laue's latest patents focus on methods for the synthesis of chiral kynurenine compounds. These methods are designed for large-scale manufacture and ensure the production of chiral kynurenines with high chemical purity and high chiral purity. The innovative techniques provided in these patents are crucial for advancing the synthesis processes in the pharmaceutical and chemical sectors.
Career Highlights
Klaus Laue is currently associated with Vistagen Therapeutics, Inc., where he continues to apply his expertise in the development of new compounds. His work is instrumental in enhancing the efficiency and effectiveness of chemical synthesis methods.
Collaborations
Laue collaborates with esteemed colleagues such as Stefan Abele and Roland A Breitenmoser. These partnerships contribute to the advancement of research and innovation in their respective fields.
Conclusion
Klaus Laue's contributions to the synthesis of chiral kynurenine compounds highlight his role as a significant inventor in the field of chemistry. His innovative methods and collaborations pave the way for future advancements in chemical synthesis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile